Versatility of Cancer Associated Fibroblasts: Commendable Targets for Anti-tumor Therapy

Area of Science:

• Oncology
• Cancer Biology
• Immunology

Background:

• Tumor growth, metastasis, and drug resistance are significantly influenced by the tumor microenvironment (TME).
• Cancer-Associated Fibroblasts (CAFs) play a complex and critical role in modulating the TME and are intricately linked to tumor progression.
• Understanding CAF interactions, origination, and activation is vital for developing effective cancer treatments.

Purpose of the Study:

• To provide a comprehensive review of Cancer-Associated Fibroblasts (CAFs).
• To highlight potential therapeutic targets within CAFs for TME regulation.
• To discuss current clinical trials and drugs targeting CAFs in cancer therapy.

Main Methods:

• Literature review of existing research on CAFs and their role in cancer.
• Analysis of CAF interactions with tumor cells and the TME.
• Examination of current therapeutic strategies and clinical trials targeting CAFs.

Main Results:

• CAFs exhibit genetic stability and anti-immunosupportive properties, making them potential targets for anti-tumor therapy.
• CAF functions can be modulated through various pathways including the immune system, growth factors (e.g., TGF), and TME components (e.g., hypoxia, ECM).
• CAFs present vulnerabilities exploitable by single or combination anti-cancer therapies for synergistic effects.

Conclusions:

• CAFs are highly vulnerable to targeted anti-cancer therapies, offering potential for synergistic or additive effects.
• Further research into CAF origination mechanisms, bio-markers, and precise activities is essential.
• Targeting CAFs holds significant promise for developing novel therapeutic strategies against cancer, with ongoing pre-clinical and clinical investigations.